Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. Summary
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
29.19 28.9 28.51 28.31 28.45 Last
24504710 19324560 15156500 12159970 9093105 Volume
+1.25% -0.99% -1.35% -0.70% +0.49% Change
Estimated financial data (e)
Sales 2021 5 812 M 912 M 912 M
Net income 2021 1 875 M 294 M 294 M
Net cash position 2021 1 805 M 283 M 283 M
P/E ratio 2021 27,6x
Yield 2021 1,32%
Sales 2022 7 053 M 1 106 M 1 106 M
Net income 2022 2 276 M 357 M 357 M
Net cash position 2022 2 476 M 388 M 388 M
P/E ratio 2022 22,7x
Yield 2022 1,59%
Capitalization 51 903 M 8 140 M 8 141 M
EV / Sales 2021 8,62x
EV / Sales 2022 7,01x
Nbr of Employees 2 887
Free-Float 52,7%
More Financials
Company
HUALAN BIOLOGICAL ENGINEERING, INC. is a China-based company principally engaged in the research, development, production and sales of blood products. It also produces vaccine products and biological engineering products. The Company's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus... 
More about the company
Ratings of Hualan Biological Engineering Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about HUALAN BIOLOGICAL ENGINEERING INC.
10/29Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended S..
CI
08/29Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended Jun..
CI
06/16Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for the Ye..
CI
04/29Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended..
CI
04/20HUALAN BIOLOGICAL ENGINEERING : to Produce Russia's Sputnik COVID-19 Vaccine in China
MT
03/30Hualan Biological Engineering Inc. Proposes Final Dividend for 2020
CI
03/17Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended Dec..
CI
2020LG shakes up loss-making phone business, to outsource lower-end models
RE
2020Samsung may discontinue high-end Galaxy Note smartphones - sources
RE
2020Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended S..
CI
2020Samsung Electronics profit likely at two-year high after Huawei orders, phone recovery
RE
2020Samsung Elec profit likely at 2-year high after Huawei orders, phone recovery
RE
2020Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended Jun..
CI
2020Verdict in first 1MDB case packs risk for Malaysian government
RE
2020Hualan Biological Engineering Plans to List Vaccine Unit on Shenzhen Chinext Board
CI
More news
News in other languages on HUALAN BIOLOGICAL ENGINEERING INC.
06/16Hualan Biological Engineering Inc. annonce un dividende final en espèces sur les action..
04/20Hualan Biological va produire en Chine le vaccin russe Sputnik COVID-19
2020Kretschmann mahnt einheitliches Vorgehen bei Fan-Frage an
2020BVB-Profi Delaney sieht Dänemark bei Fan-Rückkehr als Vorbild
2020En Chine, 182 nouveaux milliardaires en un an
More news
Chart HUALAN BIOLOGICAL ENGINEERING INC.
Duration : Period :
Hualan Biological Engineering Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUALAN BIOLOGICAL ENGINEERING INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 28,45 CNY
Average target price 41,22 CNY
Spread / Average Target 44,9%
EPS Revisions
Managers and Directors
Kang An Chairman & General Manager
Jun Min Xie Chief Financial Officer & Board Secretary
Chao Yuan Ma Chairman-Supervisory Board
Pei Tang Huang Independent Director
Yun Long Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HUALAN BIOLOGICAL ENGINEERING INC.-32.65%8 140
GILEAD SCIENCES, INC.19.40%87 255
BIONTECH SE310.30%83 098
REGENERON PHARMACEUTICALS31.23%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819